1
|
Verheyen N, Auer J, Bonaros N, Buchacher T, Dalos D, Grimm M, Mayr A, Rab A, Reinstadler S, Scherr D, Toth GG, Weber T, Zach DK, Zaruba MM, Zimpfer D, Rainer PP, Pölzl G. Austrian consensus statement on the diagnosis and management of hypertrophic cardiomyopathy. Wien Klin Wochenschr 2024; 136:571-597. [PMID: 39352517 PMCID: PMC11445290 DOI: 10.1007/s00508-024-02442-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/27/2024] [Indexed: 10/04/2024]
Abstract
Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease that is characterized by left ventricular hypertrophy unexplained by secondary causes. Based on international epidemiological data, around 20,000-40,000 patients are expected to be affected in Austria. Due to the wide variety of clinical and morphological manifestations the diagnosis can be difficult and the disease therefore often goes unrecognized. HCM is associated with a substantial reduction in quality of life and can lead to sudden cardiac death, especially in younger patients. Early and correct diagnosis, including genetic testing, is essential for comprehensive counselling of patients and their families and for effective treatment. The latter is especially true as an effective treatment of outflow tract obstruction has recently become available in the form of a first in class cardiac myosin ATPase inhibitor, as a noninvasive alternative to established septal reduction therapies. The aim of this Austrian consensus statement is to summarize the recommendations of international guidelines with respect to the genetic background, pathophysiology, diagnostics and management in the context of the Austrian healthcare system and resources, and to present them in easy to understand algorithms.
Collapse
Affiliation(s)
- Nicolas Verheyen
- Division of Cardiology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036, Graz, Austria.
| | - Johannes Auer
- Department of Internal Medicine 1 with Cardiology and Intensive Care, St. Josef Hospital Braunau, Braunau, Austria
- Paracelsus Medical University Salzburg, Salzburg, Austria
| | - Nikolaos Bonaros
- Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria
| | - Tamara Buchacher
- Department of Internal Medicine and Cardiology, Klinikum Klagenfurt, Klagenfurt, Austria
| | - Daniel Dalos
- Department of Cardiology, University Clinic of Internal Medicine II, Medical University of Vienna, Vienna, Austria
| | - Michael Grimm
- Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria
| | - Agnes Mayr
- University Clinic of Radiology, Medical University of Innsbruck, Innsbruck, Austria
| | - Anna Rab
- Department Internal Medicine I, Kardinal Schwarzenberg Klinikum, Schwarzach, Austria
| | - Sebastian Reinstadler
- Department of Cardiology and Angiology, Medical University Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria
| | - Daniel Scherr
- Division of Cardiology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036, Graz, Austria
| | - Gabor G Toth
- Division of Cardiology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036, Graz, Austria
| | - Thomas Weber
- Department Innere Medizin II, Cardiology and Intensive Care Medicine, Klinikum Wels-Grieskirchen, Wels, Austria
| | - David K Zach
- Division of Cardiology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036, Graz, Austria
| | - Marc-Michael Zaruba
- Department of Cardiology and Angiology, Medical University Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria
| | - Daniel Zimpfer
- Division of Cardiology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036, Graz, Austria
- Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria
| | - Peter P Rainer
- Division of Cardiology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036, Graz, Austria
- BioTech Med, Graz, Austria
- Department of Medicine, St. Johann in Tirol General Hospital, St. Johann in Tirol, Austria
| | - Gerhard Pölzl
- Department of Cardiology and Angiology, Medical University Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria.
| |
Collapse
|
9
|
Wang J, Li Y, Yang F, Bravo L, Wan K, Xu Y, Cheng W, Sun J, Zhu Y, Zhu T, Gkoutos GV, Han Y, Chen Y. Fractal Analysis: Prognostic Value of Left Ventricular Trabecular Complexity Cardiovascular MRI in Participants with Hypertrophic Cardiomyopathy. Radiology 2020; 298:71-79. [PMID: 33078997 DOI: 10.1148/radiol.2020202261] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Background The prognostic value of myocardial trabecular complexity in patients with hypertrophic cardiomyopathy (HCM) is unknown. Purpose To explore the prognostic value of myocardial trabecular complexity using fractal analysis in participants with HCM. Materials and Methods The authors prospectively enrolled participants with HCM who underwent 3.0-T cardiovascular MRI from August 2011 to October 2017. The authors also enrolled 100 age- and sex-matched healthy participants to form a comparison group. Trabeculae were quantified with fractal analysis of cine slices to estimate the fractal dimension (FD). Participants with HCM were divided into normal and high FD groups according to the upper limit of normal reference value from the healthy group. The primary end point was defined as all-cause mortality and aborted sudden cardiac death. The secondary end point was the composite of the primary end point and readmission to the hospital owing to heart failure. Internal validation was performed using the bootstrapping method. Results A total of 378 participants with HCM (median age, 50 years; age range, 40-61 years; 207 men) and 100 healthy participants (median age, 46 years; age range, 36-59 years; 55 women) were included in this study. During the median follow-up of 33 months ± 18 (standard deviation), the increased maximal apical FD (≥1.325) had a higher risk of the primary and secondary end points than those with a normal FD (<1.325) (P = .01 and P = .04, respectively). Furthermore, Cox analysis revealed that left ventricular maximal apical FD (hazard ratio range, 1.001-1.008; all P < .05) provided significant prognostic value to predict the primary and secondary end points after adjustment for the European Society of Cardiology predictors and late gadolinium enhancement. Internal validation showed that left ventricular maximal apical FD retained a good performance in predicting the primary end points with an area under the curve of 0.70 ± 0.03. Conclusion Left ventricular apical fractal dimension, which reflects myocardial trabecular complexity, was an independent predictor of the primary and secondary end points in patients with hypertrophic cardiomyopathy. © RSNA, 2020 Online supplemental material is available for this article. See also the editorial by Captur and Moon in this issue.
Collapse
Affiliation(s)
- Jie Wang
- From the Department of Cardiology (J.W., Y.L., F.Y., Y.X., Y.C.), Department of Radiology (W.C., J.S., Y.C.), Department of Geriatrics (K.W.), Center of Rare Diseases (Y.C.), and Medical Big Data Center (T.Z.), West China Hospital, Sichuan University, Guoxue Xiang No. 37, Chengdu, Sichuan 610041, China; Paul C. Lauterbur Research Centre for Biomedical Imaging, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, P. R. China (Y.Z.); College of Medical and Dental Sciences, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, England (J.W., L.B., G.V.G.); Medical Research Council Health Data Research, Midlands Site, Birmingham, England (G.V.G.); and Department of Medicine (Cardiovascular Division), University of Pennsylvania, Philadelphia, Pa (Y.H.)
| | - Yuancheng Li
- From the Department of Cardiology (J.W., Y.L., F.Y., Y.X., Y.C.), Department of Radiology (W.C., J.S., Y.C.), Department of Geriatrics (K.W.), Center of Rare Diseases (Y.C.), and Medical Big Data Center (T.Z.), West China Hospital, Sichuan University, Guoxue Xiang No. 37, Chengdu, Sichuan 610041, China; Paul C. Lauterbur Research Centre for Biomedical Imaging, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, P. R. China (Y.Z.); College of Medical and Dental Sciences, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, England (J.W., L.B., G.V.G.); Medical Research Council Health Data Research, Midlands Site, Birmingham, England (G.V.G.); and Department of Medicine (Cardiovascular Division), University of Pennsylvania, Philadelphia, Pa (Y.H.)
| | - Fuyao Yang
- From the Department of Cardiology (J.W., Y.L., F.Y., Y.X., Y.C.), Department of Radiology (W.C., J.S., Y.C.), Department of Geriatrics (K.W.), Center of Rare Diseases (Y.C.), and Medical Big Data Center (T.Z.), West China Hospital, Sichuan University, Guoxue Xiang No. 37, Chengdu, Sichuan 610041, China; Paul C. Lauterbur Research Centre for Biomedical Imaging, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, P. R. China (Y.Z.); College of Medical and Dental Sciences, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, England (J.W., L.B., G.V.G.); Medical Research Council Health Data Research, Midlands Site, Birmingham, England (G.V.G.); and Department of Medicine (Cardiovascular Division), University of Pennsylvania, Philadelphia, Pa (Y.H.)
| | - Laura Bravo
- From the Department of Cardiology (J.W., Y.L., F.Y., Y.X., Y.C.), Department of Radiology (W.C., J.S., Y.C.), Department of Geriatrics (K.W.), Center of Rare Diseases (Y.C.), and Medical Big Data Center (T.Z.), West China Hospital, Sichuan University, Guoxue Xiang No. 37, Chengdu, Sichuan 610041, China; Paul C. Lauterbur Research Centre for Biomedical Imaging, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, P. R. China (Y.Z.); College of Medical and Dental Sciences, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, England (J.W., L.B., G.V.G.); Medical Research Council Health Data Research, Midlands Site, Birmingham, England (G.V.G.); and Department of Medicine (Cardiovascular Division), University of Pennsylvania, Philadelphia, Pa (Y.H.)
| | - Ke Wan
- From the Department of Cardiology (J.W., Y.L., F.Y., Y.X., Y.C.), Department of Radiology (W.C., J.S., Y.C.), Department of Geriatrics (K.W.), Center of Rare Diseases (Y.C.), and Medical Big Data Center (T.Z.), West China Hospital, Sichuan University, Guoxue Xiang No. 37, Chengdu, Sichuan 610041, China; Paul C. Lauterbur Research Centre for Biomedical Imaging, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, P. R. China (Y.Z.); College of Medical and Dental Sciences, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, England (J.W., L.B., G.V.G.); Medical Research Council Health Data Research, Midlands Site, Birmingham, England (G.V.G.); and Department of Medicine (Cardiovascular Division), University of Pennsylvania, Philadelphia, Pa (Y.H.)
| | - Yuanwei Xu
- From the Department of Cardiology (J.W., Y.L., F.Y., Y.X., Y.C.), Department of Radiology (W.C., J.S., Y.C.), Department of Geriatrics (K.W.), Center of Rare Diseases (Y.C.), and Medical Big Data Center (T.Z.), West China Hospital, Sichuan University, Guoxue Xiang No. 37, Chengdu, Sichuan 610041, China; Paul C. Lauterbur Research Centre for Biomedical Imaging, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, P. R. China (Y.Z.); College of Medical and Dental Sciences, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, England (J.W., L.B., G.V.G.); Medical Research Council Health Data Research, Midlands Site, Birmingham, England (G.V.G.); and Department of Medicine (Cardiovascular Division), University of Pennsylvania, Philadelphia, Pa (Y.H.)
| | - Wei Cheng
- From the Department of Cardiology (J.W., Y.L., F.Y., Y.X., Y.C.), Department of Radiology (W.C., J.S., Y.C.), Department of Geriatrics (K.W.), Center of Rare Diseases (Y.C.), and Medical Big Data Center (T.Z.), West China Hospital, Sichuan University, Guoxue Xiang No. 37, Chengdu, Sichuan 610041, China; Paul C. Lauterbur Research Centre for Biomedical Imaging, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, P. R. China (Y.Z.); College of Medical and Dental Sciences, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, England (J.W., L.B., G.V.G.); Medical Research Council Health Data Research, Midlands Site, Birmingham, England (G.V.G.); and Department of Medicine (Cardiovascular Division), University of Pennsylvania, Philadelphia, Pa (Y.H.)
| | - Jiayu Sun
- From the Department of Cardiology (J.W., Y.L., F.Y., Y.X., Y.C.), Department of Radiology (W.C., J.S., Y.C.), Department of Geriatrics (K.W.), Center of Rare Diseases (Y.C.), and Medical Big Data Center (T.Z.), West China Hospital, Sichuan University, Guoxue Xiang No. 37, Chengdu, Sichuan 610041, China; Paul C. Lauterbur Research Centre for Biomedical Imaging, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, P. R. China (Y.Z.); College of Medical and Dental Sciences, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, England (J.W., L.B., G.V.G.); Medical Research Council Health Data Research, Midlands Site, Birmingham, England (G.V.G.); and Department of Medicine (Cardiovascular Division), University of Pennsylvania, Philadelphia, Pa (Y.H.)
| | - Yanjie Zhu
- From the Department of Cardiology (J.W., Y.L., F.Y., Y.X., Y.C.), Department of Radiology (W.C., J.S., Y.C.), Department of Geriatrics (K.W.), Center of Rare Diseases (Y.C.), and Medical Big Data Center (T.Z.), West China Hospital, Sichuan University, Guoxue Xiang No. 37, Chengdu, Sichuan 610041, China; Paul C. Lauterbur Research Centre for Biomedical Imaging, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, P. R. China (Y.Z.); College of Medical and Dental Sciences, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, England (J.W., L.B., G.V.G.); Medical Research Council Health Data Research, Midlands Site, Birmingham, England (G.V.G.); and Department of Medicine (Cardiovascular Division), University of Pennsylvania, Philadelphia, Pa (Y.H.)
| | - Tingxi Zhu
- From the Department of Cardiology (J.W., Y.L., F.Y., Y.X., Y.C.), Department of Radiology (W.C., J.S., Y.C.), Department of Geriatrics (K.W.), Center of Rare Diseases (Y.C.), and Medical Big Data Center (T.Z.), West China Hospital, Sichuan University, Guoxue Xiang No. 37, Chengdu, Sichuan 610041, China; Paul C. Lauterbur Research Centre for Biomedical Imaging, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, P. R. China (Y.Z.); College of Medical and Dental Sciences, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, England (J.W., L.B., G.V.G.); Medical Research Council Health Data Research, Midlands Site, Birmingham, England (G.V.G.); and Department of Medicine (Cardiovascular Division), University of Pennsylvania, Philadelphia, Pa (Y.H.)
| | - Georgios V Gkoutos
- From the Department of Cardiology (J.W., Y.L., F.Y., Y.X., Y.C.), Department of Radiology (W.C., J.S., Y.C.), Department of Geriatrics (K.W.), Center of Rare Diseases (Y.C.), and Medical Big Data Center (T.Z.), West China Hospital, Sichuan University, Guoxue Xiang No. 37, Chengdu, Sichuan 610041, China; Paul C. Lauterbur Research Centre for Biomedical Imaging, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, P. R. China (Y.Z.); College of Medical and Dental Sciences, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, England (J.W., L.B., G.V.G.); Medical Research Council Health Data Research, Midlands Site, Birmingham, England (G.V.G.); and Department of Medicine (Cardiovascular Division), University of Pennsylvania, Philadelphia, Pa (Y.H.)
| | - Yuchi Han
- From the Department of Cardiology (J.W., Y.L., F.Y., Y.X., Y.C.), Department of Radiology (W.C., J.S., Y.C.), Department of Geriatrics (K.W.), Center of Rare Diseases (Y.C.), and Medical Big Data Center (T.Z.), West China Hospital, Sichuan University, Guoxue Xiang No. 37, Chengdu, Sichuan 610041, China; Paul C. Lauterbur Research Centre for Biomedical Imaging, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, P. R. China (Y.Z.); College of Medical and Dental Sciences, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, England (J.W., L.B., G.V.G.); Medical Research Council Health Data Research, Midlands Site, Birmingham, England (G.V.G.); and Department of Medicine (Cardiovascular Division), University of Pennsylvania, Philadelphia, Pa (Y.H.)
| | - Yucheng Chen
- From the Department of Cardiology (J.W., Y.L., F.Y., Y.X., Y.C.), Department of Radiology (W.C., J.S., Y.C.), Department of Geriatrics (K.W.), Center of Rare Diseases (Y.C.), and Medical Big Data Center (T.Z.), West China Hospital, Sichuan University, Guoxue Xiang No. 37, Chengdu, Sichuan 610041, China; Paul C. Lauterbur Research Centre for Biomedical Imaging, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, P. R. China (Y.Z.); College of Medical and Dental Sciences, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, England (J.W., L.B., G.V.G.); Medical Research Council Health Data Research, Midlands Site, Birmingham, England (G.V.G.); and Department of Medicine (Cardiovascular Division), University of Pennsylvania, Philadelphia, Pa (Y.H.)
| |
Collapse
|